NASDAQ
No price data available for this timeframe.
Karyopharm Therapeutics Inc. (KPTI) has a current ratio of 1.12x as of Monday, May 25, 2026. This represents a 68.25% decrease compared to its 12-month average of 3.53x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.